A Gap on Judgment of Fertility and the Need for Contraception Between Physicians and Patients With Rheumatic Diseases: A Multicenter Questionnaire Survey.
Moriyama Mayuko M, Murakawa Yohko Y, Nagafuchi Hiroko H, Shirota Yuko Y et al.
Effective contraception is essential for women of reproductive age with rheumatic disease (RD), specifically those receiving teratogenic drugs, and physicians should recognize that these women may wish to conceive or control their fertility. This study aimed to evaluate the status of preconception care and contraception use, awareness, and counseling among women with RD in Japan. This cross-sectional questionnaire survey included Japanese women with RD (age: 18-45 years) and their attending physicians, conducted between September 2023 and May 2024 at 14 medical institutions. Patient and physician responses were linked and analyzed. In total, 157 patients completed the survey. Of these, 35% of patients wished to conceive in the future and 38% were aware of their current need for contraception. The results revealed a gap between physicians' and patients' judgment of fertility and the need for contraception. Most patients used less effective contraceptive methods (condoms: 67.1%; withdrawal: 20.5%). Although patients were aware of the need for contraception, only 12% had received specific contraception instructions from their healthcare providers, whereas 39% had never received contraception counseling. Most of the patients decided on contraceptive methods themselves or together with their partners. One patient who tested positive for antiphospholipid antibodies used contraindicated estrogen-containing contraceptives. Significant deficiencies exist in contraception counseling and awareness among women with RD. Proactive and system-building approaches are urgently required to improve preconception care and reproductive safety in this population.